Aspiriant Holdings S3’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.06M Buy
23,542
+545
+2% +$46.7K 0.89% 43
2015
Q3
$1.86M Buy
22,997
+75
+0.3% +$6.53K 0.86% 45
2015
Q2
$2.04M Buy
22,922
+328
+1% +$28.7K 0.81% 47
2015
Q1
$1.96M Buy
22,594
+105
+0.5% +$8.81K 0.78% 46
2014
Q4
$1.9M Sell
22,489
-2,022
-8% -$158K 0.79% 47
2014
Q3
$1.73M Sell
24,511
-1,120
-4% -$79.8K 0.69% 48
2014
Q2
$1.78M Buy
25,631
+871
+4% +$61.3K 0.71% 49
2014
Q1
$1.86M Buy
+24,760
New +$1.85M 0.78% 45

Other funds holding ESRX

Aspiriant Holdings S3's ESRX Position: Q4 2015 in Review

Aspiriant Holdings S3 increased its Express Scripts Holding Company (ESRX) stake by 2.4% in Q4 2015, buying an estimated $46.7K and bringing the position to 23,542 shares worth $2.06M. The position accounts for 0.89% of the portfolio, ranked #43.

Aspiriant Holdings S3 first reported a position in ESRX in Q1 2014 and has held it in 8 quarters since. 1,295 funds tracked by Wall St. Rank hold ESRX as of Q4 2015.

  • Aspiriant Holdings S3 held 23,542 shares of Express Scripts Holding Company worth $2.06M as of Q4 2015.
  • Aspiriant Holdings S3 bought 545 Express Scripts Holding Company shares in Q4 2015, an estimated $46.7K.
  • Express Scripts Holding Company made up 0.89% of Aspiriant Holdings S3's portfolio in Q4 2015, its #43 holding.
  • Aspiriant Holdings S3 first reported a position in Express Scripts Holding Company in Q1 2014 and has held it in 8 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.